Literature DB >> 26996669

Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.

F Garibaldi1, E Falcone1, D Trisciuoglio1, T Colombo2,3, K Lisek4,5, D Walerych4, G Del Sal4,5, P Paci2,3, G Bossi1,6, G Piaggio1, A Gurtner1.   

Abstract

Downregulation of microRNAs (miRNAs) is commonly observed in cancers and promotes tumorigenesis suggesting that miRNAs may function as tumor suppressors. However, the mechanism through which miRNAs are regulated in cancer, and the connection between oncogenes and miRNA biogenesis remain poorly understood. The TP53 tumor-suppressor gene is mutated in half of human cancers resulting in an oncogene with gain-of-function activities. Here we demonstrate that mutant p53 (mutp53) oncoproteins modulate the biogenesis of a subset of miRNAs in cancer cells inhibiting their post-transcriptional maturation. Interestingly, among these miRNAs several are also downregulated in human tumors. By confocal, co-immunoprecipitation and RNA-chromatin immunoprecipitation experiments, we show that endogenous mutp53 binds and sequesters RNA helicases p72/82 from the microprocessor complex, interfering with Drosha-pri-miRNAs association. In agreement with this, the overexpression of p72 leads to an increase of mature miRNAs levels. Moreover, functional experiments demonstrate the oncosuppressive role of mutp53-dependent miRNAs (miR-517a, -519a, -218, -105). Our study highlights a previously undescribed mechanism by which mutp53 interferes with Drosha-p72/82 association leading, at least in part, to miRNA deregulation observed in cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26996669     DOI: 10.1038/onc.2016.51

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

1.  Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.

Authors:  Silvia Di Agostino; Sabrina Strano; Velia Emiliozzi; Valentina Zerbini; Marcella Mottolese; Ada Sacchi; Giovanni Blandino; Giulia Piaggio
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

2.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.

Authors:  Masaki Mori; Robinson Triboulet; Morvarid Mohseni; Karin Schlegelmilch; Kriti Shrestha; Fernando D Camargo; Richard I Gregory
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

Review 3.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

Review 4.  MicroRNAs in the p53 network: micromanagement of tumour suppression.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

5.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

Review 6.  MiR-200, a new star miRNA in human cancer.

Authors:  Xiangling Feng; Zhengming Wang; Rebecca Fillmore; Yaguang Xi
Journal:  Cancer Lett       Date:  2013-11-19       Impact factor: 8.679

7.  Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.

Authors:  P M Neilsen; J E Noll; S Mattiske; C P Bracken; P A Gregory; R B Schulz; S P Lim; R Kumar; R J Suetani; G J Goodall; D F Callen
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

8.  The transcriptional repressor hDaxx potentiates p53-dependent apoptosis.

Authors:  Monica Gostissa; Manuela Morelli; Fiamma Mantovani; Elisa Guida; Silvano Piazza; Licio Collavin; Claudio Brancolini; Claudio Schneider; Giannino Del Sal
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

9.  BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex.

Authors:  Shinji Kawai; Atsuo Amano
Journal:  J Cell Biol       Date:  2012-04-09       Impact factor: 10.539

10.  Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Authors:  P Dong; M Karaayvaz; N Jia; M Kaneuchi; J Hamada; H Watari; S Sudo; J Ju; N Sakuragi
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

View more
  21 in total

1.  Mutant p53-Nrf2 axis regulates the proteasome machinery in cancer.

Authors:  Kamil Lisek; Dawid Walerych; Giannino Del Sal
Journal:  Mol Cell Oncol       Date:  2016-09-02

2.  Multi-omics reveals global effects of mutant p53 gain-of-function.

Authors:  Dawid Walerych; Kamil Lisek; Giannino Del Sal
Journal:  Cell Cycle       Date:  2016-07-26       Impact factor: 4.534

3.  Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.

Authors:  Dawid Walerych; Kamil Lisek; Roberta Sommaggio; Silvano Piazza; Yari Ciani; Emiliano Dalla; Katarzyna Rajkowska; Katarzyna Gaweda-Walerych; Eleonora Ingallina; Claudia Tonelli; Marco J Morelli; Angela Amato; Vincenzo Eterno; Alberto Zambelli; Antonio Rosato; Bruno Amati; Jacek R Wiśniewski; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2016-06-27       Impact factor: 28.824

Review 4.  Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.

Authors:  Mariama El Baroudi; Jean-Pascal Machiels; Sandra Schmitz
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

5.  Integrated analysis of miRNA and mRNA expression profiles in p53-edited PFF cells.

Authors:  Chuanmin Qiao; Weiwei Liu; Haoyun Jiang; Maozhang He; Qiang Yang; Yuyun Xing
Journal:  Cell Cycle       Date:  2020-03-26       Impact factor: 4.534

6.  Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci.

Authors:  Emmanuela Falcone; Luca Grandoni; Francesca Garibaldi; Isabella Manni; Giancarlo Filligoi; Giulia Piaggio; Aymone Gurtner
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

7.  A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.

Authors:  Giulia Regazzo; Irene Terrenato; Manuela Spagnuolo; Mariantonia Carosi; Gaetana Cognetti; Lucia Cicchillitti; Francesca Sperati; Veronica Villani; Carmine Carapella; Giulia Piaggio; Andrea Pelosi; Maria Giulia Rizzo
Journal:  J Exp Clin Cancer Res       Date:  2016-07-30

Review 8.  Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.

Authors:  Giuseppa Pistritto; Daniela Trisciuoglio; Claudia Ceci; Alessia Garufi; Gabriella D'Orazi
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

9.  DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development.

Authors:  Luqing Zhao; Yitao Mao; Yuelong Zhao; Yanong He
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

Review 10.  Alternative mechanisms of miR-34a regulation in cancer.

Authors:  Eva Slabáková; Zoran Culig; Ján Remšík; Karel Souček
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.